Do Nervin and Vitamin C Help in Acute Ischemic Stroke with Hemiplegia?
No, neither Nervin (a topical lidocaine/menthol pain cream) nor vitamin C are recommended for improving outcomes in acute ischemic stroke causing hemiplegia. These agents have no established role in stroke recovery based on current evidence-based guidelines.
Why These Agents Are Not Recommended
Nervin (Topical Pain Cream)
Based on the FDA drug label, Nervin is a topical pain-relieving cream containing lidocaine HCl and menthol 1. This is a peripheral pain medication designed for localized musculoskeletal pain relief, not a neurological treatment. It has:
- No mechanism of action relevant to stroke pathophysiology
- No evidence for neuroprotection or stroke recovery
- No role in treating central nervous system injury
Vitamin C
The evidence for vitamin C in acute ischemic stroke is definitively negative:
Guideline Evidence: The American Heart Association/American Stroke Association guidelines explicitly state: "No medication with putative neuroprotective effects has yet been shown to be useful for treatment of patients with acute ischemic stroke" 2. The 2013 guidelines further emphasize that "at present, no pharmacological or non-pharmacological treatments with putative neuroprotective actions have demonstrated efficacy in improving outcomes after ischemic stroke, and therefore, other neuroprotective agents are not recommended" 3.
Clinical Trial Evidence:
- A 2007 case-control study of vitamin C 1000 mg daily in ischemic stroke patients showed no significant improvement in functional recovery (TFIM, FIM-Cognition, FIM-Motor scores), length of stay, or discharge disposition 4
- A 2010 study administering 500 mg/day IV vitamin C for 10 days found that while it elevated antioxidant levels, it did not substantially improve clinical or functional status after 3 months 5
- A 2021 scoping review concluded that clinical studies reported no patient-centered benefit from vitamin C, despite promising pre-clinical data 6
Critical Dosing Gap: The pre-clinical studies showing benefit used approximately 120 mg/kg in animals 6, while human trials used only ~10 mg/kg (500-1000 mg total daily dose) 6, 5, 4. However, even with this knowledge, no high-dose human trials have demonstrated efficacy, and such doses are not recommended by any guideline.
What IS Recommended for Acute Ischemic Stroke
Evidence-based acute treatments include:
- Intravenous thrombolysis (rtPA 0.9 mg/kg, max 90 mg) within 3 hours of onset 2
- Endovascular thrombectomy for large vessel occlusions 7, 8
- Aspirin within 48 hours (small but proven benefit) 2
- Comprehensive stroke unit care with rehabilitation 2
For hemiplegia specifically:
- Early mobilization and physical therapy
- Prevention of complications (DVT prophylaxis, positioning to prevent contractures, fall prevention) 9
- Nutritional support if dysphagia present 9
Common Pitfalls to Avoid
- Do not delay proven therapies to administer unproven supplements like vitamin C
- Do not confuse topical pain medications (like Nervin) with neurological treatments
- Do not extrapolate animal study results to human stroke care—over 100 neuroprotective agents showed promise in animals but failed in humans 10
- Do not use antioxidants as stroke treatment despite theoretical appeal—multiple large trials of free radical scavengers (NXY-059, tirilazad, ebselen) have all been negative 10
The Bottom Line
Focus resources and time on proven interventions: rapid thrombolysis/thrombectomy evaluation, aspirin, stroke unit care, and comprehensive rehabilitation. Vitamin C and Nervin have no role in stroke management and should not be prescribed for this indication 2, 3, 7.